Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
11/2005
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256127 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation
11/17/2005US20050256123 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2005US20050256122 Substituted pyridazinones
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1594848A1 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
11/16/2005CN1227234C Substituted iminoazines
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/09/2005CN1694871A Imidazolopyridines and methods of making and using the same
11/09/2005CN1694698A Pyrazolopyridines and methods of making and using the same
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
10/2005
10/27/2005WO2005100323A1 Process for preparing pyridazinone compounds
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239655 3-heterocyclyl substituted benzoic acid derivatives
10/27/2005CA2563225A1 Process for preparing pyridazinone compounds
10/27/2005CA2562244A1 Cyclic compounds
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234236 Process for preparing pyridazinone compounds
10/20/2005US20050234062 Such as 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-2H-acetamide; phosphodiesterase inhibitors; for treatment of respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/18/2005CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
10/18/2005CA2190129C Therapeutic phenoxyalkylpyridazines and intermediates therefor
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/12/2005EP1583967A2 Method for inhibiting the replication of herpes viruses
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680274A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
10/11/2005US6953853 Phospholipase inhbitors; antiinflammatory agents; respiratory system disorders
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581478A1 Dhodh-inhibitors and method for their identification
10/05/2005EP1581477A1 Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
10/05/2005EP1156039B1 Pyridazin-3-one derivatives and medicines containing the same
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1676518A 4-substituted phenyl pyridazine compound and herbicidal activity
10/04/2005US6951945 Heteroaromatic glucokinase activators
09/2005
09/29/2005WO2005090317A1 Non-nucleoside reverse transcriptase inhibitors
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215554 viricides; therapy for genetic engineered virus; polymerase inhibitor
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005CA2559552A1 Benzyl-pyridazinone derivatives as non-nucleoside reverse transcriptase inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1578741A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220682C Heterocycle derivatives inhibiting factor Xa
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005US20050209462 Synthesis of benzimidate from benzoic acid
09/22/2005US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors
09/22/2005US20050209232 Useful for treating inflammatory, immunological, and integrin-mediated disorders such as inflammatory bowel disease; 2-(3,3-Diisopropyl-ureido)-3-[4-(5-methoxy-2-methyl-3-oxo-2,3-dihydro-pyridazin-4-yl)-phenyl]-propionic acid for example
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1575926A1 New pyridazin-3(2h)-one derivatives
09/21/2005EP1575922A1 Biphenyl derivatives and their use as fungicides
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050202973 Aryl-alkyne compounds as herbicides
09/14/2005EP1572630A1 Antibacterial agents
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1082309B1 Process for the preparation of a 3(2h)-pyridazinone- 4-substituted amino- 5-chloro- derivative
09/14/2005CN1668603A Pyridazin-3(2h)-one derivatives as PDE4 inhibitors
09/13/2005CA2181901C Pyridazinone derivatives
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/08/2005US20050197349 Pyrrolo[2,3-D]pyrimidine compounds
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571148A1 3-phenyl-cinnoline homologue and antitumor agent containing the same
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP0888310B1 Cinnoline derivatives and use as medicine
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080317A2 Therapeutic amide derivatives
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005DE102004008141A1 Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren Guanidine compounds and their use as binding partners for 5-HT5 receptors
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 85